Literature DB >> 11304805

The use of counterflow centrifugation to enrich gonadotropes and somatotropes.

G V Childs1, G Unabia.   

Abstract

Counterflow centrifugation produces populations of gonadotropes or growth hormone (GH) cells enriched to 90% in a Beckman elutriator. The pituitary populations are first separated by size into three fractions applying different flow rates, stimulated with either gonadotropin-releasing hormone (GnRH) to enlarge the gonadotropes or growth hormone-releasing hormone (GHRH) to enlarge the somatotropes for 3 hr. The fractions are re-eluted, first at the original flow rates and then at higher flow rates to separate enlarged gonadotropes or somatotropes. Most other cell types are reduced to less than 5%. However, co-storage of GH and gonadotropin antigens is seen in either population. Enriched gonadotropes or somatotropes can be used in studies of proliferation, autocrine or paracrine regulation, or ion channel functions.(J Histochem Cytochem 49:663-664, 2001)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304805     DOI: 10.1177/002215540104900514

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  3 in total

1.  Rapid, efficient isolation of murine gonadotropes and their use in revealing control of follicle-stimulating hormone by paracrine pituitary factors.

Authors:  Joyce C Wu; Pei Su; Nedal W Safwat; Joseph Sebastian; William L Miller
Journal:  Endocrinology       Date:  2004-08-19       Impact factor: 4.736

2.  A Sex-Dependent, Tropic Role for Leptin in the Somatotrope as a Regulator of POU1F1 and POU1F1-Dependent Hormones.

Authors:  Angela K Odle; Melody L Allensworth-James; Noor Akhter; Mohsin Syed; Anessa C Haney; Melanie MacNicol; Angus M MacNicol; Gwen V Childs
Journal:  Endocrinology       Date:  2016-08-29       Impact factor: 4.736

Review 3.  Hormones in synergy: regulation of the pituitary gonadotropin genes.

Authors:  Varykina G Thackray; Pamela L Mellon; Djurdjica Coss
Journal:  Mol Cell Endocrinol       Date:  2009-09-10       Impact factor: 4.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.